The colicin G, H and X determinants encode microcins M and H47, which might utilize the catecholate siderophore receptors FepA, Cir, Fiu and IroN.
about
Analysis of the genome structure of the nonpathogenic probiotic Escherichia coli strain Nissle 1917Siderophore-based iron acquisition and pathogen controlThe host response to the probiotic Escherichia coli strain Nissle 1917: specific up-regulation of the proinflammatory chemokine MCP-1Insights from 100 Years of Research with Probiotic E. ColiInteractions between the microbiota and pathogenic bacteria in the gutIdentification and characterization of microcin S, a new antibacterial peptide produced by probiotic Escherichia coli G3/10Siderophore peptide, a new type of post-translationally modified antibacterial peptide with potent activity.Comparative genomics of recent Shiga toxin-producing Escherichia coli O104:H4: short-term evolution of an emerging pathogenBacteriocin-encoding genes and ExPEC virulence determinants are associated in human fecal Escherichia coli strains.Bacteriocin synthesis in uropathogenic and commensal Escherichia coli: colicin E1 is a potential virulence factorFunctional interactions between the carbon and iron utilization regulators, Crp and Fur, in Escherichia coliTreatment of inflammatory bowel disease associated E. coli with ciprofloxacin and E. coli Nissle in the streptomycin-treated mouse intestineExperimental administration of the probiotic Escherichia coli strain Nissle 1917 results in decreased diversity of E. coli strains in pigs.Bacteriocinogeny in experimental pigs treated with indomethacin and Escherichia coli Nissle.Clinical use of E. coli Nissle 1917 in inflammatory bowel disease.Unique activity spectrum of colicin FY: all 110 characterized Yersinia enterocolitica isolates were colicin FY susceptible.Bactericidal activity of both secreted and nonsecreted microcin E492 requires the mannose permease.Escherichia coli EDL933 requires gluconeogenic nutrients to successfully colonize the intestines of streptomycin-treated mice precolonized with E. coli Nissle 1917.No vacancy: how beneficial microbes cooperate with immunity to provide colonization resistance to pathogensThe probiotic Escherichia coli strain Nissle 1917 (EcN) stops acute diarrhoea in infants and toddlers.Genome-Wide Screening Identifies Six Genes That Are Associated with Susceptibility to Escherichia coli Microcin PDIDextran sodium sulfate-induced inflammation alters the expression of proteins by intestinal Escherichia coli strains in a gnotobiotic mouse model.Novel colicin Fy of Yersinia frederiksenii inhibits pathogenic Yersinia strains via YiuR-mediated reception, TonB import, and cell membrane pore formation.Differential Effects of Escherichia coli Nissle and Lactobacillus rhamnosus Strain GG on Human Rotavirus Binding, Infection, and B Cell Immunity.Human extraintestinal pathogenic Escherichia coli strains differ in prevalence of virulence factors, phylogroups, and bacteriocin determinantsSalmonella stress management and its relevance to behaviour during intestinal colonisation and infection.Natural products as mediators of disease.Probiotics: properties, examples, and specific applications.Biosynthetic tailoring of microcin E492m: post-translational modification affords an antibacterial siderophore-peptide conjugate.Use of mchI encoding immunity to the antimicrobial peptide microcin H47 as a plasmid selection marker in attenuated bacterial live vectors.Microcin determinants are associated with B2 phylogroup of human fecal Escherichia coli isolatesThe dual role of bacteriocins as anti- and probiotics.Persistence of colicinogenic Escherichia coli in the mouse gastrointestinal tract.Rationale for probiotic treatment strategies in inflammatory bowel disease.Microcins mediate competition among Enterobacteriaceae in the inflamed gut.pMPES: A Modular Peptide Expression System for the Delivery of Antimicrobial Peptides to the Site of Gastrointestinal Infections Using Probiotics.An Escherichia coli Nissle 1917 missense mutant colonizes the streptomycin-treated mouse intestine better than the wild type but is not a better probiotic.Microcin PDI regulation and proteolytic cleavage are unique among known microcins.Role of F1C fimbriae, flagella, and secreted bacterial components in the inhibitory effect of probiotic Escherichia coli Nissle 1917 on atypical enteropathogenic E. coli infection.Escherichia coli Nissle 1917 (Mutaflor): new insights into an old probiotic bacterium.
P2860
Q24561803-F8D1D21B-6604-421D-9055-C8DC1A94D2DBQ24681774-299F4DCA-EBB1-44EF-ABD4-A76369940AA0Q25256884-BBCE3CE5-C83F-4857-8144-16FC60820F06Q28079219-CCE3ED3F-6E36-48B8-A220-3BF24900898DQ28080209-78EFD413-F0F7-4522-9287-434EBFF8973EQ28482036-E3BC2533-892A-4B5A-AED4-1AFEA1E0EB04Q33202132-933E5C1C-CCF5-46CF-826D-8ED2AEC0D3DFQ33405438-9777BEDB-FF94-4E76-9721-44E8A4802BC2Q33612852-6E9D94C6-A1EE-4B5B-B878-EE10FB220724Q33746988-7D5C3351-10F5-4065-A9C0-78E78CD203AEQ33758245-467D0E31-B0D9-4506-B55C-98A11CC7D562Q33996821-0F6669B8-3B1D-4FEB-A915-1BF97259C9C8Q34083538-8F057E5A-05DE-414A-B519-EF1B19CE9FE7Q34579758-465052A9-37E2-49AF-81E5-9CE5338AFF46Q34744012-14FC17BB-D0D6-46A1-B21B-E290DDD29F07Q35067652-8C44BF10-070B-46E3-935F-9B16E70956E3Q35130137-CB63F5DB-EA3D-4599-AD48-0553747FF9B2Q35439818-70297A1F-7C42-4591-AE62-D69570E42B14Q35478936-058E7181-7AB8-4753-A5FD-69EE7B052CE8Q35646959-29867D07-4B7E-4BFC-9C97-F341E688172BQ35713362-53A8A2A8-9E00-4AD6-A269-EE501682F234Q35804807-E9DD21FA-8728-4D52-B4F6-09806E040729Q35867716-BC1D8A92-3283-40B4-A517-12F0E12E794AQ35901914-C981F569-DAD3-44E7-9F25-94E512B18FF8Q36137582-2A07D2C6-1E66-4AB3-87FA-89A7FB87159EQ36197324-9B4B449F-9EFA-4AF4-9145-A92799287E7DQ36200942-21A06653-E2C0-4BCD-B2AB-47E9E0637D6CQ36629073-18D1B563-1478-44C9-89C1-6BCDD0F3CB20Q36848822-E587492C-2248-4AE4-9F1A-EB73B9D7CB9EQ36898558-C25D92E6-9CA3-446A-975C-6565EDD70C8FQ36999765-8093620B-AF26-4694-A745-535EC6EF0D32Q37160785-C7E1EC3E-E136-42D2-96FD-8C337CA8D205Q37341276-4DE2A173-6B7B-4948-95DD-9F9A779236BBQ37345932-CACBE633-6DB5-4075-8C42-F75ABAAA25DEQ37486385-EA63F209-E6BD-4D52-A396-F922FDC6B279Q37542328-ECD81EDD-4AA2-4C84-AA7C-507A9EE89A82Q37546369-1191B959-77D7-43D7-A7F3-17FD99F83FABQ37644356-893C2C3D-137F-4554-92F0-1EC729EB2995Q37713374-57B622F2-4BCF-4E46-8B2C-44FFE51BD92FQ37969596-D4822318-1EFB-4893-A8D0-CFBA3229D4BB
P2860
The colicin G, H and X determinants encode microcins M and H47, which might utilize the catecholate siderophore receptors FepA, Cir, Fiu and IroN.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
The colicin G, H and X determi ...... ptors FepA, Cir, Fiu and IroN.
@en
The colicin G, H and X determi ...... ptors FepA, Cir, Fiu and IroN.
@nl
type
label
The colicin G, H and X determi ...... ptors FepA, Cir, Fiu and IroN.
@en
The colicin G, H and X determi ...... ptors FepA, Cir, Fiu and IroN.
@nl
prefLabel
The colicin G, H and X determi ...... ptors FepA, Cir, Fiu and IroN.
@en
The colicin G, H and X determi ...... ptors FepA, Cir, Fiu and IroN.
@nl
P2093
P356
P1433
P1476
The colicin G, H and X determi ...... eptors FepA, Cir, Fiu and IroN
@en
P2093
P304
P356
10.1099/MIC.0.26396-0
P50
P577
2003-09-01T00:00:00Z